Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Part 3: NAFLD/NASH (30 mins)

See the latest on NASH diagnosis and management, including noninvasive tests, monitoring for advanced fibrosis, and the future of treatment options.
Paul Y. Kwo, MD
Program Director
Manal F. Abdelmalek, MD, MPH
Oluwaseun Falade-Nwulia, MBBS, MPH
Released: December 17, 2019 Expiration: No longer available for credit

This program is divided into several short segments which you can step through using the Video Chapters widget.

Related Content

Expert commentary discussing the early identification and prognosis of NAFLD, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 16, 2021 Expired: March 15, 2022

Interactive video from Dr. Manal Abdelmale and CCO: Who is at risk and who should be evaluated for progression to advanced fibrosis in NASH?

Manal F. Abdelmalek, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 15, 2021 Expired: March 14, 2022

Unlocked slides from Manal Abdelmalek, MD, MPH, and CCO: Who is at risk and who should be evaluated for progression to advanced fibrosis in NASH?

Manal F. Abdelmalek, MD, MPH Released: March 15, 2021

Unlocked slides from Brent Tetri, MD, and CCO: impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease

Brent A. Neuschwander-Tetri, MD Released: February 3, 2021

Video Chapters


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue